| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |